[{"address1": "500 Unicorn Park Drive", "address2": "Suite 303", "city": "Woburn", "state": "MA", "zip": "01801", "country": "United States", "phone": "781 222 9600", "website": "https://www.replimune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.", "fullTimeEmployees": 331, "companyOfficers": [{"maxAge": 1, "name": "Mr. Philip  Astley-Sparke F.S.A.", "age": 53, "title": "Executive Chairman", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 960520, "exercisedValue": 0, "unexercisedValue": 435967}, {"maxAge": 1, "name": "Ms. Emily Luisa Hill", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 593047, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Konstantinos  Xynos M.B.A., M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 668686, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sushil  Patel Ph.D.", "age": 53, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 665050, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Schwendenman", "age": 48, "title": "Chief Accounting Officer & Treasurer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shawn  Glidden J.D.", "title": "Senior Vice President of General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camilo  Garcia M.A., M.B.A.", "title": "Chief Human Resource Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Sarchi", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Bullock", "title": "Chief Manufacturing Officer & Framingham Site Head", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nina  Aragam", "title": "Senior Vice President of Portfolio Strategy & Program Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.16, "open": 7.19, "dayLow": 6.93, "dayHigh": 8.055, "regularMarketPreviousClose": 7.16, "regularMarketOpen": 7.19, "regularMarketDayLow": 6.93, "regularMarketDayHigh": 8.055, "payoutRatio": 0.0, "beta": 0.677, "forwardPE": -2.9753532, "volume": 499594, "regularMarketVolume": 499594, "averageVolume": 854985, "averageVolume10days": 1244970, "averageDailyVolume10Day": 1244970, "bid": 7.92, "ask": 8.06, "bidSize": 1, "askSize": 1, "marketCap": 616403392, "fiftyTwoWeekLow": 4.92, "fiftyTwoWeekHigh": 17.0, "fiftyDayAverage": 9.858, "twoHundredDayAverage": 11.27175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 90927832, "profitMargins": 0.0, "floatShares": 53003113, "sharesOutstanding": 77014800, "sharesShort": 8827180, "sharesShortPriorMonth": 9546116, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.1146, "heldPercentInsiders": 0.04614, "heldPercentInstitutions": 1.0283, "shortRatio": 9.48, "shortPercentOfFloat": 0.15810001, "impliedSharesOutstanding": 77014800, "bookValue": 6.264, "priceToBook": 1.27773, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -228242000, "trailingEps": -3.07, "forwardEps": -2.69, "enterpriseToEbitda": -0.385, "52WeekChange": 0.06389296, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 8.0037, "targetHighPrice": 31.0, "targetLowPrice": 14.0, "targetMeanPrice": 21.125, "targetMedianPrice": 20.0, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 536539008, "totalCashPerShare": 6.967, "ebitda": -236204992, "totalDebt": 76041000, "quickRatio": 11.268, "currentRatio": 11.434, "debtToEquity": 15.764, "returnOnAssets": -0.26304, "returnOnEquity": -0.50501, "freeCashflow": -112702376, "operatingCashflow": -184684992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "REPL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1746724529, "exchange": "NMS", "messageBoardId": "finmb_571664452", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "averageDailyVolume3Month": 854985, "fiftyTwoWeekLowChange": 3.0837002, "fiftyTwoWeekLowChangePercent": 0.6267683, "fiftyTwoWeekRange": "4.92 - 17.0", "fiftyTwoWeekHighChange": -8.9963, "fiftyTwoWeekHighChangePercent": -0.5291941, "fiftyTwoWeekChangePercent": 6.389296, "earningsTimestamp": 1739365200, "earningsTimestampStart": 1747225800, "earningsTimestampEnd": 1747657800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.07, "epsForward": -2.69, "epsCurrentYear": -2.81277, "priceEpsCurrentYear": -2.845487, "fiftyDayAverageChange": -1.8542995, "fiftyDayAverageChangePercent": -0.188101, "twoHundredDayAverageChange": -3.2680502, "twoHundredDayAverageChangePercent": -0.2899328, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "REGULAR", "regularMarketChangePercent": 11.783525, "regularMarketPrice": 8.0037, "shortName": "Replimune Group, Inc.", "longName": "Replimune Group, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532093400000, "regularMarketChange": 0.8437004, "regularMarketDayRange": "6.93 - 8.055", "fullExchangeName": "NasdaqGS", "displayName": "Replimune", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]